Global and United States Blood-Brain Barrier Transport Drugs Market Report & Forecast 2022-2028

Global and United States Blood-Brain Barrier Transport Drugs Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Blood-Brain Barrier Transport Drugs Product Introduction
1.2 Global Blood-Brain Barrier Transport Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Blood-Brain Barrier Transport Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Blood-Brain Barrier Transport Drugs Sales in Volume for the Year 2017-2028
1.3 United States Blood-Brain Barrier Transport Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Blood-Brain Barrier Transport Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Blood-Brain Barrier Transport Drugs Sales in Volume for the Year 2017-2028
1.4 Blood-Brain Barrier Transport Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Blood-Brain Barrier Transport Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Blood-Brain Barrier Transport Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Blood-Brain Barrier Transport Drugs Market Dynamics
1.5.1 Blood-Brain Barrier Transport Drugs Industry Trends
1.5.2 Blood-Brain Barrier Transport Drugs Market Drivers
1.5.3 Blood-Brain Barrier Transport Drugs Market Challenges
1.5.4 Blood-Brain Barrier Transport Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Blood-Brain Barrier Transport Drugs Market Segment by Type
2.1.1 Carrier-mediated Transport
2.1.2 Receptor-mediated Transport
2.1.3 Absorptive-mediated Transport
2.1.4 Active Efflux Transport
2.1.5 Others
2.2 Global Blood-Brain Barrier Transport Drugs Market Size by Type
2.2.1 Global Blood-Brain Barrier Transport Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Blood-Brain Barrier Transport Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Blood-Brain Barrier Transport Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Blood-Brain Barrier Transport Drugs Market Size by Type
2.3.1 United States Blood-Brain Barrier Transport Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Blood-Brain Barrier Transport Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Blood-Brain Barrier Transport Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Blood-Brain Barrier Transport Drugs Market Segment by Application
3.1.1 Alzheimer's Disease
3.1.2 Epilepsy
3.1.3 Parkinson's Disease
3.1.4 Multiple Sclerosis
3.1.5 Hunter's Syndrome
3.1.6 Brain Cancer
3.1.7 Others
3.2 Global Blood-Brain Barrier Transport Drugs Market Size by Application
3.2.1 Global Blood-Brain Barrier Transport Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Blood-Brain Barrier Transport Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Blood-Brain Barrier Transport Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Blood-Brain Barrier Transport Drugs Market Size by Application
3.3.1 United States Blood-Brain Barrier Transport Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Blood-Brain Barrier Transport Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Blood-Brain Barrier Transport Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Blood-Brain Barrier Transport Drugs Competitor Landscape by Company
4.1 Global Blood-Brain Barrier Transport Drugs Market Size by Company
4.1.1 Top Global Blood-Brain Barrier Transport Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Blood-Brain Barrier Transport Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Blood-Brain Barrier Transport Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Blood-Brain Barrier Transport Drugs Price by Manufacturer (2017-2022)
4.2 Global Blood-Brain Barrier Transport Drugs Concentration Ratio (CR)
4.2.1 Blood-Brain Barrier Transport Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Blood-Brain Barrier Transport Drugs in 2021
4.2.3 Global Blood-Brain Barrier Transport Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Blood-Brain Barrier Transport Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Blood-Brain Barrier Transport Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Blood-Brain Barrier Transport Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Blood-Brain Barrier Transport Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Blood-Brain Barrier Transport Drugs Market Size by Company
4.5.1 Top Blood-Brain Barrier Transport Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Blood-Brain Barrier Transport Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Blood-Brain Barrier Transport Drugs Sales by Players (2020, 2021 & 2022)
5 Global Blood-Brain Barrier Transport Drugs Market Size by Region
5.1 Global Blood-Brain Barrier Transport Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Blood-Brain Barrier Transport Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Blood-Brain Barrier Transport Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Blood-Brain Barrier Transport Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Blood-Brain Barrier Transport Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Blood-Brain Barrier Transport Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Blood-Brain Barrier Transport Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Blood-Brain Barrier Transport Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Blood-Brain Barrier Transport Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Blood-Brain Barrier Transport Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Blood-Brain Barrier Transport Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Blood-Brain Barrier Transport Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Blood-Brain Barrier Transport Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Blood-Brain Barrier Transport Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Blood-Brain Barrier Transport Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Blood-Brain Barrier Transport Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Blood-Brain Barrier Transport Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Cyclenium
7.1.1 Cyclenium Corporation Information
7.1.2 Cyclenium Description and Business Overview
7.1.3 Cyclenium Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Cyclenium Blood-Brain Barrier Transport Drugs Products Offered
7.1.5 Cyclenium Recent Development
7.2 BioAdvance
7.2.1 BioAdvance Corporation Information
7.2.2 BioAdvance Description and Business Overview
7.2.3 BioAdvance Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 BioAdvance Blood-Brain Barrier Transport Drugs Products Offered
7.2.5 BioAdvance Recent Development
7.3 EIP Pharma
7.3.1 EIP Pharma Corporation Information
7.3.2 EIP Pharma Description and Business Overview
7.3.3 EIP Pharma Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 EIP Pharma Blood-Brain Barrier Transport Drugs Products Offered
7.3.5 EIP Pharma Recent Development
7.4 Bioasis
7.4.1 Bioasis Corporation Information
7.4.2 Bioasis Description and Business Overview
7.4.3 Bioasis Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Bioasis Blood-Brain Barrier Transport Drugs Products Offered
7.4.5 Bioasis Recent Development
7.5 Immune Pharmaceuticals
7.5.1 Immune Pharmaceuticals Corporation Information
7.5.2 Immune Pharmaceuticals Description and Business Overview
7.5.3 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Products Offered
7.5.5 Immune Pharmaceuticals Recent Development
7.6 AZ Therapies
7.6.1 AZ Therapies Corporation Information
7.6.2 AZ Therapies Description and Business Overview
7.6.3 AZ Therapies Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 AZ Therapies Blood-Brain Barrier Transport Drugs Products Offered
7.6.5 AZ Therapies Recent Development
7.7 Palobiofarma
7.7.1 Palobiofarma Corporation Information
7.7.2 Palobiofarma Description and Business Overview
7.7.3 Palobiofarma Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Palobiofarma Blood-Brain Barrier Transport Drugs Products Offered
7.7.5 Palobiofarma Recent Development
7.8 Bach Pharma
7.8.1 Bach Pharma Corporation Information
7.8.2 Bach Pharma Description and Business Overview
7.8.3 Bach Pharma Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Bach Pharma Blood-Brain Barrier Transport Drugs Products Offered
7.8.5 Bach Pharma Recent Development
7.9 BrainsGate
7.9.1 BrainsGate Corporation Information
7.9.2 BrainsGate Description and Business Overview
7.9.3 BrainsGate Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 BrainsGate Blood-Brain Barrier Transport Drugs Products Offered
7.9.5 BrainsGate Recent Development
7.10 CarThera
7.10.1 CarThera Corporation Information
7.10.2 CarThera Description and Business Overview
7.10.3 CarThera Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 CarThera Blood-Brain Barrier Transport Drugs Products Offered
7.10.5 CarThera Recent Development
7.11 Dainippon Sumitomo Pharma
7.11.1 Dainippon Sumitomo Pharma Corporation Information
7.11.2 Dainippon Sumitomo Pharma Description and Business Overview
7.11.3 Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Products Offered
7.11.5 Dainippon Sumitomo Pharma Recent Development
7.12 Fluorinov Pharma
7.12.1 Fluorinov Pharma Corporation Information
7.12.2 Fluorinov Pharma Description and Business Overview
7.12.3 Fluorinov Pharma Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Fluorinov Pharma Products Offered
7.12.5 Fluorinov Pharma Recent Development
7.13 Fondazione Telethon
7.13.1 Fondazione Telethon Corporation Information
7.13.2 Fondazione Telethon Description and Business Overview
7.13.3 Fondazione Telethon Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Fondazione Telethon Products Offered
7.13.5 Fondazione Telethon Recent Development
7.14 Minoryx
7.14.1 Minoryx Corporation Information
7.14.2 Minoryx Description and Business Overview
7.14.3 Minoryx Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Minoryx Products Offered
7.14.5 Minoryx Recent Development
7.15 NewGen Therapeutics
7.15.1 NewGen Therapeutics Corporation Information
7.15.2 NewGen Therapeutics Description and Business Overview
7.15.3 NewGen Therapeutics Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.15.4 NewGen Therapeutics Products Offered
7.15.5 NewGen Therapeutics Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Blood-Brain Barrier Transport Drugs Industry Chain Analysis
8.2 Blood-Brain Barrier Transport Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Blood-Brain Barrier Transport Drugs Distributors
8.3 Blood-Brain Barrier Transport Drugs Production Mode & Process
8.4 Blood-Brain Barrier Transport Drugs Sales and Marketing
8.4.1 Blood-Brain Barrier Transport Drugs Sales Channels
8.4.2 Blood-Brain Barrier Transport Drugs Distributors
8.5 Blood-Brain Barrier Transport Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Blood-Brain Barrier Transport Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Blood-Brain Barrier Transport Drugs Market Trends
Table 3. Blood-Brain Barrier Transport Drugs Market Drivers
Table 4. Blood-Brain Barrier Transport Drugs Market Challenges
Table 5. Blood-Brain Barrier Transport Drugs Market Restraints
Table 6. Global Blood-Brain Barrier Transport Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Blood-Brain Barrier Transport Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Blood-Brain Barrier Transport Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Blood-Brain Barrier Transport Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Blood-Brain Barrier Transport Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Blood-Brain Barrier Transport Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Blood-Brain Barrier Transport Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Blood-Brain Barrier Transport Drugs Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Blood-Brain Barrier Transport Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Blood-Brain Barrier Transport Drugs Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Blood-Brain Barrier Transport Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Blood-Brain Barrier Transport Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood-Brain Barrier Transport Drugs as of 2021)
Table 18. Top Players of Blood-Brain Barrier Transport Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Blood-Brain Barrier Transport Drugs Product Type
Table 20. Date of International Manufacturers Enter into Blood-Brain Barrier Transport Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Blood-Brain Barrier Transport Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Blood-Brain Barrier Transport Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Blood-Brain Barrier Transport Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Blood-Brain Barrier Transport Drugs Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Blood-Brain Barrier Transport Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Blood-Brain Barrier Transport Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Blood-Brain Barrier Transport Drugs Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Blood-Brain Barrier Transport Drugs Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Blood-Brain Barrier Transport Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Blood-Brain Barrier Transport Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Blood-Brain Barrier Transport Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Blood-Brain Barrier Transport Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Blood-Brain Barrier Transport Drugs Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Blood-Brain Barrier Transport Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Blood-Brain Barrier Transport Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Blood-Brain Barrier Transport Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Blood-Brain Barrier Transport Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Blood-Brain Barrier Transport Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Blood-Brain Barrier Transport Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Blood-Brain Barrier Transport Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Cyclenium Corporation Information
Table 43. Cyclenium Description and Business Overview
Table 44. Cyclenium Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. Cyclenium Blood-Brain Barrier Transport Drugs Product
Table 46. Cyclenium Recent Development
Table 47. BioAdvance Corporation Information
Table 48. BioAdvance Description and Business Overview
Table 49. BioAdvance Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. BioAdvance Product
Table 51. BioAdvance Recent Development
Table 52. EIP Pharma Corporation Information
Table 53. EIP Pharma Description and Business Overview
Table 54. EIP Pharma Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 55. EIP Pharma Product
Table 56. EIP Pharma Recent Development
Table 57. Bioasis Corporation Information
Table 58. Bioasis Description and Business Overview
Table 59. Bioasis Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 60. Bioasis Product
Table 61. Bioasis Recent Development
Table 62. Immune Pharmaceuticals Corporation Information
Table 63. Immune Pharmaceuticals Description and Business Overview
Table 64. Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 65. Immune Pharmaceuticals Product
Table 66. Immune Pharmaceuticals Recent Development
Table 67. AZ Therapies Corporation Information
Table 68. AZ Therapies Description and Business Overview
Table 69. AZ Therapies Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 70. AZ Therapies Product
Table 71. AZ Therapies Recent Development
Table 72. Palobiofarma Corporation Information
Table 73. Palobiofarma Description and Business Overview
Table 74. Palobiofarma Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 75. Palobiofarma Product
Table 76. Palobiofarma Recent Development
Table 77. Bach Pharma Corporation Information
Table 78. Bach Pharma Description and Business Overview
Table 79. Bach Pharma Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 80. Bach Pharma Product
Table 81. Bach Pharma Recent Development
Table 82. BrainsGate Corporation Information
Table 83. BrainsGate Description and Business Overview
Table 84. BrainsGate Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 85. BrainsGate Product
Table 86. BrainsGate Recent Development
Table 87. CarThera Corporation Information
Table 88. CarThera Description and Business Overview
Table 89. CarThera Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 90. CarThera Product
Table 91. CarThera Recent Development
Table 92. Dainippon Sumitomo Pharma Corporation Information
Table 93. Dainippon Sumitomo Pharma Description and Business Overview
Table 94. Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 95. Dainippon Sumitomo Pharma Product
Table 96. Dainippon Sumitomo Pharma Recent Development
Table 97. Fluorinov Pharma Corporation Information
Table 98. Fluorinov Pharma Description and Business Overview
Table 99. Fluorinov Pharma Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 100. Fluorinov Pharma Product
Table 101. Fluorinov Pharma Recent Development
Table 102. Fondazione Telethon Corporation Information
Table 103. Fondazione Telethon Description and Business Overview
Table 104. Fondazione Telethon Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 105. Fondazione Telethon Product
Table 106. Fondazione Telethon Recent Development
Table 107. Minoryx Corporation Information
Table 108. Minoryx Description and Business Overview
Table 109. Minoryx Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 110. Minoryx Product
Table 111. Minoryx Recent Development
Table 112. NewGen Therapeutics Corporation Information
Table 113. NewGen Therapeutics Description and Business Overview
Table 114. NewGen Therapeutics Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 115. NewGen Therapeutics Product
Table 116. NewGen Therapeutics Recent Development
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Blood-Brain Barrier Transport Drugs Customers List
Table 120. Blood-Brain Barrier Transport Drugs Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Blood-Brain Barrier Transport Drugs Product Picture
Figure 2. Global Blood-Brain Barrier Transport Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Blood-Brain Barrier Transport Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Blood-Brain Barrier Transport Drugs Sales 2017-2028 (K Pcs)
Figure 5. United States Blood-Brain Barrier Transport Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Blood-Brain Barrier Transport Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Blood-Brain Barrier Transport Drugs Sales 2017-2028 (K Pcs)
Figure 8. United States Blood-Brain Barrier Transport Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Blood-Brain Barrier Transport Drugs Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Blood-Brain Barrier Transport Drugs Report Years Considered
Figure 11. Product Picture of Carrier-mediated Transport
Figure 12. Product Picture of Receptor-mediated Transport
Figure 13. Product Picture of Absorptive-mediated Transport
Figure 14. Product Picture of Active Efflux Transport
Figure 15. Product Picture of Others
Figure 16. Global Blood-Brain Barrier Transport Drugs Market Share by Type in 2022 & 2028
Figure 17. Global Blood-Brain Barrier Transport Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 18. Global Blood-Brain Barrier Transport Drugs Sales Market Share in Value by Type (2017-2028)
Figure 19. Global Blood-Brain Barrier Transport Drugs Sales by Type (2017-2028) & (K Pcs)
Figure 20. Global Blood-Brain Barrier Transport Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 21. Global Blood-Brain Barrier Transport Drugs Price by Type (2017-2028) & (USD/Pcs)
Figure 22. United States Blood-Brain Barrier Transport Drugs Market Share by Type in 2022 & 2028
Figure 23. United States Blood-Brain Barrier Transport Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 24. United States Blood-Brain Barrier Transport Drugs Sales Market Share in Value by Type (2017-2028)
Figure 25. United States Blood-Brain Barrier Transport Drugs Sales by Type (2017-2028) & (K Pcs)
Figure 26. United States Blood-Brain Barrier Transport Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 27. United States Blood-Brain Barrier Transport Drugs Price by Type (2017-2028) & (USD/Pcs)
Figure 28. Product Picture of Alzheimer's Disease
Figure 29. Product Picture of Epilepsy
Figure 30. Product Picture of Parkinson's Disease
Figure 31. Product Picture of Multiple Sclerosis
Figure 32. Product Picture of Hunter's Syndrome
Figure 33. Product Picture of Brain Cancer
Figure 34. Product Picture of Others
Figure 35. Global Blood-Brain Barrier Transport Drugs Market Share by Application in 2022 & 2028
Figure 36. Global Blood-Brain Barrier Transport Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. Global Blood-Brain Barrier Transport Drugs Sales Market Share in Value by Application (2017-2028)
Figure 38. Global Blood-Brain Barrier Transport Drugs Sales by Application (2017-2028) & (K Pcs)
Figure 39. Global Blood-Brain Barrier Transport Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 40. Global Blood-Brain Barrier Transport Drugs Price by Application (2017-2028) & (USD/Pcs)
Figure 41. United States Blood-Brain Barrier Transport Drugs Market Share by Application in 2022 & 2028
Figure 42. United States Blood-Brain Barrier Transport Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 43. United States Blood-Brain Barrier Transport Drugs Sales Market Share in Value by Application (2017-2028)
Figure 44. United States Blood-Brain Barrier Transport Drugs Sales by Application (2017-2028) & (K Pcs)
Figure 45. United States Blood-Brain Barrier Transport Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 46. United States Blood-Brain Barrier Transport Drugs Price by Application (2017-2028) & (USD/Pcs)
Figure 47. North America Blood-Brain Barrier Transport Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 48. North America Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 49. U.S. Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Canada Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Europe Blood-Brain Barrier Transport Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 52. Europe Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. Germany Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. France Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. U.K. Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Italy Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Russia Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Asia-Pacific Blood-Brain Barrier Transport Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 59. Asia-Pacific Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 60. China Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Japan Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. South Korea Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. India Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Australia Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Taiwan Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Indonesia Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Thailand Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Malaysia Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Philippines Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Latin America Blood-Brain Barrier Transport Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 71. Latin America Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 72. Mexico Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Brazil Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Argentina Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Middle East & Africa Blood-Brain Barrier Transport Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 76. Middle East & Africa Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 77. Turkey Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 78. Saudi Arabia Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 79. U.A.E Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 80. Blood-Brain Barrier Transport Drugs Value Chain
Figure 81. Blood-Brain Barrier Transport Drugs Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs